DEAD box polypeptide 58 (DDX58; RIG-I); interferon induced with helicase C domain 1 (IFIH1; MDA5) BriefCommunication Pages: 5 - 5
Neuroblastoma Ras viral oncogene ( NRAS ); lysophospholipase I (LYPLA1; APT-1) BriefCommunication Pages: 7 - 7
c-Myc (MYC); SUMO1 activating enzyme subunit 1 (SAE1); ubiquitin-like modifier activating enzyme 2 (UBA2; SAE2) BriefCommunication Pages: 8 - 8
Vascular cell adhesion molecule-1 (VCAM-1); integrin α4 (VLA-4; CD49D) BriefCommunication Pages: 9 - 9
PD-1 receptor (PDCD1; PD-1; CD279); programmed cell death 1 ligand 1 (CD274 molecule; PD-L1; B7-H1); lymphocyte-activation gene 3 (LAG3; CD223) BriefCommunication Pages: 18 - 18
Guanine nucleotide binding protein (G protein) α-inhibiting activity polypeptide 2 (GNAI2) BriefCommunication Pages: 20 - 20
Metabotropic glutamate receptor subtype 5 (mGluR5; GRM5); mGluR7 (GRM7); mGluR8 (GRM8) BriefCommunication Pages: 22 - 22
High throughput sequencing of tumor tissue to guide clinical trial enrollment BriefCommunication Pages: 25 - 25
Quantification of minimal residual disease in chronic lymphocytic leukemia (CLL) following hematopoietic stem cell transplant BriefCommunication Pages: 26 - 26
Real-time classification of glioma tumors with mass spectrometry–based lipid profiling BriefCommunication Pages: 27 - 27
Selective arylation of imidazoles to synthesize Tasigna nilotinib and its analogs BriefCommunication Pages: 28 - 28
Prophylactic vaccination with antibody-expressing adenoviral transgenes BriefCommunication Pages: 29 - 29